The excellent news: drug shortages in 2023 have been down within the US from their current peak between 2010 to 2012.
The unhealthy information: Drug shortages in 2023 have been the very best they’ve been since 2012.
These findings are from an FDA Report back to Congress. Of observe, shortages for biologic medicine (ruled by CBER) elevated loads in 2023. FDA writes that:
CY 2023 has been a difficult yr for shortages. For instance, the notable improve in new shortages of CBER-regulated organic merchandise was because of manufacturing issues and high quality procedures at one producer that skilled international provide chain points associated to the dearth of some supplies and parts wanted for the manufacturing course of. FDA has seen producers in the US and overseas proceed to expertise high quality points and battle with capability constraints.
You may learn the complete report right here.
